Hosenkoside K exhibits significant anti-inflammatory activity, making it a candidate for development in treatments targeting chronic inflammatory diseases. It has been studied for its ability to inhibit pro-inflammatory cytokines, such as TNF-α and IL-6, in cellular models. This property suggests potential use in managing conditions like arthritis, inflammatory bowel disease, or dermatitis. Additionally, Hosenkoside K demonstrates moderate antioxidant effects, which may contribute to cellular protection against oxidative stress. This dual action—anti-inflammatory and antioxidant—positions it as a compound of interest in nutraceuticals and cosmeceuticals, particularly in formulations aimed at skin aging or metabolic inflammation. Research is ongoing to evaluate its bioavailability and safety profile for future pharmaceutical applications.